No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Everolimus plus leuprorelin and letrozole improves progression-free survival in HR⁺, HER2⁻ metastatic breast cancer patients with visceral metastases

byTeddy Guo

January 13, 2021

in StudyGraphics

Reading Time: 1 min read

Thirty minutes of moderate physical activity associated with significantly improved outcomes for patients with obesity and metabolic syndrome

RelatedReports

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025

StudyGraphics

#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

June 17, 2025

One-year of Herceptin preferable to two-year regimen

Oncology

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

April 11, 2025

Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025

Compliance-linked incentives increase infant immunizations rates in rural India

Novel OPV2-c1 and OPV2-c2 vaccines offer promising safety, tolerability, and immunogenicity in healthy adults

Early developmental screening of children with single ventricle physiology may not identify future deficits

#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction

#VisualAbstract: Carboplatin holds potential as an adjunct therapy for recurrent high-grade glioma treatment

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports